Fresenius Medical Care AG & Co. KGaA

  • WKN: 578580
  • ISIN: DE0005785802
  • Land: Deutschland

Nachricht vom 11.06.2018 | 10:13

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art.
5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052

11.06.2018 / 10:13
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Share buy-back - 2nd Interim Report and Final Report In the period from 4 June 2018 until and including 8 June 2018, a total of 213,226 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care'), which was announced on 25 May 2018 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 4 June 2018 43,500 85.3555 5 June 2018 43,500 86.6331 6 June 2018 42,294 86.7213 7 June 2018 42,863 86.7374 8 June 2018 41,069 86.3573 The total volume of shares repurchased within the framework of this share buy-back in the period from 28 May 2018 until and including 8 June 2018 therefore amounts to 431,000 shares. The weighted average share price paid for these shares amounted to EUR 86.3828. This concludes the share buy-back programme. The purchase of shares of Fresenius Medical Care within the framework of the share buy-back programme was carried out exclusively on the Frankfurt Stock Exchange via the XETRA trading platform by a credit institution commissioned by Fresenius Medical Care. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., 11 June 2018
11.06.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Germany Internet: www.freseniusmedicalcare.com End of News DGAP News Service

GBC im Fokus

UniDevice AG mit hoher Ergebnisdynamik

Die UniDevice AG weist zum Halbjahr eine hohe Umsatz- und Ergebnisdynamik auf. Der Börsenneuling agiert als Schnittstelle zwischen Distributoren und Groß- und Einzelhändler von elektronischen Geräten (vornehmlich Smartphones) und profitiert daher von der zunehmenden Nachfrage in diesem Bereich. Für 2018 peilt UniDevice die Umsatzmarke von 300 Mio. € an. Die GBC-Analysten stufen die Aktie mit einem Kursziel von 2,30 € und KAUFEN ein.

Aktueller Webcast

EQS Group AG

Half-yearly financial statements 2018

16. August 2018

Aktuelle Research-Studie

KPS AG

Original-Research: KPS AG (von GBC AG): BUY

14. August 2018